About Signos
Signos is a metabolic health platform that pairs continuous glucose monitoring (CGM) with an AI-driven app to provide real-time, personalized insights for weight management and healthy weight loss. The platform targets non-diabetic adults seeking to improve metabolic health, offering personalized meal, exercise, and lifestyle recommendations based on each user's unique glucose response. In 2025, Signos received FDA clearance for the first over-the-counter glucose monitoring system designed specifically for weight management.
Company details
Funding
Total raised
$37M
Last stage
Series B
Investors
Founders
Sharam Fouladgar-Mercer
Serial entrepreneur and former Entrepreneur-in-Residence at Shasta Ventures. Previously Founding CEO of Onclusive. Holds an MBA from Harvard Business School and a CS degree from Princeton.
LinkedInWilliam Dixon
Bill Tancer
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.